Marigold Investment Management Revenue
Investment Management • 
Hørsholm, Capital Region of Denmark, Denmark • 1-10 Employees
Marigold Investment Management revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Investment Management industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contact at Marigold Investment Management
Benny Buchardt Andersen
Ceo
Company overview
| Headquarters | Agern Alle 24, Hørsholm, Capital Region 2970, DK |
| Phone number | +4539788438 |
| Websites | |
| NAICS | 5231 |
| Keywords | Intellectual Property, Startups, Strategy, Entrepreneurship, Life Science, Research, Venture Capital, Financing, Biotech, Innovation, Drug Development, IPR, Venture Creation, Medtech, Go-To-Market, Spin Out, Scaleups, Co-Founding, Company Creation |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Marigold Investment Management Email Formats
Marigold Investment Management uses 1 email format. The most common is {first name} (e.g., john@mgim.dk), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@mgim.dk | 100% |
About Marigold Investment Management
We invest in medical biotechnology companies at the most value-creating stage. Biotech is a compelling investment because it solves significant global health challenges. We build biotech companies from breakthrough research — based on world-class Scandinavian science and structured for commercial success. World-class research becomes world-class biotech companies. We systematically de-risk each project before investment, sourcing from leading Scandinavian universities and applying 12–24 months of structured scientific and commercial validation. When we invest, the company is de-risked — with a focused plan, capable team, and a shorter path to exit. Our team brings senior experience from science, pharma, and institutional investment — with financial and operational depth rarely found in medical biotech. We design the plan and build the company together with the scientists, provide the capital — and execute, from start to exit. Our portfolio companies are focused purely on drug development — each with a clearly defined development plan and a clear path to pharma acquisition. We offer professional and institutional investors structured access to biotech companies built on rigorous science and commercial readiness. FSA Registration • Marigold Investment Management is registered under the AIFM framework (FTID: 23321) • Marigold Maturation Fund is registered under the AIF framework (FTID: 25657) What We Do We co-found, validate, and mature companies with academic inventors — and prepare them for their next owner: an international pharma company capable of bringing breakthrough medicines to market. Many groundbreaking inventions could become life-changing medicines — but are never developed, and never reach the patients they could have helped. Often, this is because academic inventors lack access to the capabilities and capital needed to bring their science to market. Marigold Investment Management is built to change that.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Marigold Investment Management has 4 employees across 4 departments.
Departments
Number of employees
Funding Data
Marigold Investment Management has never raised funding before.
France
South Africa
Canada
United States
Romania
Frequently asked questions
4.8
40,000 users
